OverviewChartNewsTraderScreen

Brainstorm Cell Therapeutics/  US10501E3009  /

IEX
11/7/2024  9:48:24 PM Chg. -0.06 Volume Bid- Ask- High Low
1.53USD -3.48% 633
Turnover: 1,023.32		 -Bid Size: - -Ask Size: - 1.66 1.53
GlobeNewswire 5/13 IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/8 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO
GlobeNewswire 1/2 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell ...
GlobeNewswire 1/2 DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investo...
GlobeNewswire 1/2 BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics I...
GlobeNewswire 1/1 BCLI FINAL DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics ...
GlobeNewswire 12/29/2023 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bra...
GlobeNewswire 12/28/2023 BCLI DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. I...
GlobeNewswire 12/28/2023 SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of ...
GlobeNewswire 12/27/2023 BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics I...
GlobeNewswire 12/27/2023 BRAINSTORM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Enc...
GlobeNewswire 12/26/2023 DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investo...
GlobeNewswire 12/26/2023 DEADLINE ALERT for DCGO, SEDG, BCLI, BCS: Law Offices of Howard G. Smith Reminds Investors of Class ...
GlobeNewswire 12/25/2023 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses ...
GlobeNewswire 12/25/2023 BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has...
Newsfile Corp 12/23/2023 ROSEN, NATIONAL TRIAL COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses to...
GlobeNewswire 12/22/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Brainstorm Cell ...
GlobeNewswire 12/21/2023 SHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. (BCLI) Investors of a...
GlobeNewswire 12/21/2023 Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire 12/21/2023 BRAINSTORM CELL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has...
Newsfile Corp 12/20/2023 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Cou...
GlobeNewswire 12/20/2023 SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Brainstorm Cell Therapeutics Inc. of ...
GlobeNewswire 12/20/2023 BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics I...
GlobeNewswire 12/19/2023 ROSEN, THE FIRST FILING FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Couns...
GlobeNewswire 12/19/2023 DEADLINE ALERT for SEDG, BCLI, BCLYF/BCS, and OTLK: The Law Offices of Frank R. Cruz Reminds Investo...